Novel encapsulation technology for oral delivery
Freund Pharmatec
| « Previous month | Next month » |
30-Sep-2005
Study suggests weakening HIV virus
30-Sep-2005 - According to new study, the virus that causes AIDS is becoming more sensitive to drug treatments, contradicting a wealth of research that demonstrates the emergence of drug resistant viral strains.
Researcher's new receptor advances drug discovery process
30-Sep-2005 - US scientists have designed a new receptor and enhanced bioassay that is set to advance the drug discovery process for diseases such as cystic fibrosis and Bartter's syndrome, tracking a...
29-Sep-2005
Analysts predict improved microarray market performance
29-Sep-2005 - According to a recent report, the emerging market for protein microarrays will experience strong growth buoyed on by the emergence of the technology's ability to detect protein expression more quickly...
Phoqus plans to raise £10-£12m via AIM listing
29-Sep-2005 - UK drug delivery company Phoqus has said it plans to list on the Alternative Investment Market (AIM) via an institutional placing that should raise proceeds of £10-£12 million.
Dutch CMO hikes production capacity
29-Sep-2005 - Contract biopharmaceutical manufacturer SynCo Bio Partners has started construction of two new manufacturing suites at its facility in Amsterdam, the Netherlands, in a move that builds on the firm's ability...
India's Matrix Labs continues down acquisition trial
29-Sep-2005 - India's Matrix Laboratories has made two acquisitions that will enhance its presence in the European and Asian markets for pharmaceutical intermediates and active pharmaceutical ingredients (APIs).
Portable labs detect water toxins faster
29-Sep-2005 - Two novel technologies, designed to check water supplies for toxins, is set to provide a new on-site monitoring approach, enhancing current utility monitoring systems that require water samples to be...
Superfos closes UK pharma packaging plant
29-Sep-2005 - Danish packaging company Superfos has continued the refocusing of its pharmaceuticals business with the closure of a UK plant that the company has deemed too small to operate efficiently.
Animal activists target children's nurseries
29-Sep-2005 - Animal activists' latest target in its campaign of terrorism has centred on a chain of children's nurseries that has links with the chemicals testing company, Huntingdon Life Sciences (HLS).
28-Sep-2005
People on the move
28-Sep-2005 - In-PharmaTechnologist.com reports its periodic round-up of personnel changes in pharmaceutical manufacturing and development.
UK firm unveils first non-toxic biocide
28-Sep-2005 - Greenbridge Environmental Control of the UK has introdueced a new cleaner and disinfectant agent, suitable for commercial scale applications, that is claimed to be the first non-toxic product of its...
SkyePharma rights issue weighs on share price
28-Sep-2005 - UK drug delivery company Skyepharma has been forced to raise funds to carry out trials of its combination drug for asthma and chronic obstructive pulmonary disease (COPD) after failing to...
Celtic Pharma declares Transfersome carrier interest
28-Sep-2005 - Celtic Pharma has announced the acquisition of a stake in IDEA - a biopharma company, which is developing targeted therapeutics based on novel, Transfersome carriers that can increase drug potency...
Patent on low-cost safety syringe filed
28-Sep-2005 - A patent covering a simple design for a safety syringe, which uses a vacuum rather than a spring to retract the needle after use and should be cheaper to manufacture...
27-Sep-2005
Advanced Biosciences takes sales into own hands
27-Sep-2005 - The Advanced Biosciences division of US specialty materials maker Rohm and Haas has decided to sell its entire range of solutions for the production of biopharmaceuticals directly to customers.
Genzyme unveils $540m expansion plan for manufacturing, R&D
27-Sep-2005 - US biotechnology major Genzyme officially opened four European facilities last week as part of a investment package eventually expected to cost $540 million (€449m).
In-bottle oxygen absorber launched by Multisorb
27-Sep-2005 - Multisorb Technologies has launched a new oxygen-absorbing product to increase the shelf life of pharmaceuticals at the ongoing Pack Expo Las Vegas exhibition.
Pliva secures new contract to make azithromycin
27-Sep-2005 - Croatian pharmaceutical company Pliva has signed a new three-year agreement with Pfizer for the bulk supply of azithromycin, the active ingredient in the antibacterial drug Zithromax.
New lab system allows macromolecule analysis
27-Sep-2005 - PANalytical has added a new focusing mirror to its range of PreFIX optics that for the first time, can analyse macromolecules using a standard, laboratory-based XRD system, rather than on...
DecisionNews Media seeks pharma industry reporter
27-Sep-2005 - DecisionNews Media is seeking a further reporter for its pharmaceuticals industry news services. Applicants must be exceptionally bright, ambitious and talented, with experience in news writing on the pharmaceuticals industry.
26-Sep-2005
Solubilising excipient gets green light in Japan
26-Sep-2005 - Eastman Chemical Co's Vitamin E TPGS has been approved as a pharmaceutical excipient for oral drug formulations in Japan by the Japanese government's Ministry of Health, Labour and Welfare.
Gerresheimer expands in US and China with GGI purchase
26-Sep-2005 - German packaging company Gerresheimer has announced plans to take over the pharmaceutical business of troubled Glass Group Inc (GGI) of the US, after a Delaware bankruptcy court approved the transaction.
Researchers add piece to cancer drug resistance
26-Sep-2005 - Researchers in the US have uncovered a contributing factor in interferon resistance of malignant melanoma cells. The finding represents a step forward in understanding of this type of cancer and...
Locostatins identified as cancer drug targets
26-Sep-2005 - A newly discovered compound, which has revealed new links between cell signalling pathways and cell migration, may suggest new avenues for novel pharmaceutical therapies for treating a variety of diseases,...
Genentech halts Avastin drug study
26-Sep-2005 - Genentech has announced that studies of Avastin in platinum-refractory ovarian cancer patients have been discontinued due to patients developing a serious bowel problem.
Galapagos and BioFocus forms new biopharma outfit
26-Sep-2005 - Galapagos has announced that its acquisition of BioFocus' would accelerate its transition to a fully integrated drug development biopharmaceutical company after the two companies reached agreement on the terms of...
Crawford resigns as FDA Commissioner
26-Sep-2005 - The US Food and Drug Administration (FDA) has found itself once again without a permanent Commissioner after the current incumbent - Lester Crawford - resigned after 18 months in the post.
Novo Nordisk sues Sanofi-Aventis over insulin injector
26-Sep-2005 - Danish pharmaceutical company Novo Nordisk has filed a lawsuit against France's Sanofi-Aventis, alleging that the latter has infringed patent protection for an insulin injection system for diabetes patients.
23-Sep-2005
Researcher outlines drug potential in targeting receptor
23-Sep-2005 - A US researcher has provided one possible molecular explanation of how IGF-1 receptor and the IRS-1 protein act as a key growth factor that regulates cell and body size. The...
22-Sep-2005
PerkinElmer and Invitrogen in ion channel deal
22-Sep-2005 - PerkinElmer and Invitrogen enter into a strategic agreement to streamline drug development in which the collaboration will combine PerkinElmer's technology for ion channel drug discovery and Invitrogen's voltage sensor probe...
Celsis, BioVentures team up on contamination detection
22-Sep-2005 - Celsis International has signed a collaboration with BioVentures to develop a microarray-based microbiological testing system to detect contamination in pharmaceutical, biotechnology and other process industries.
Queen's novel HIV research to address HIV pandemic
22-Sep-2005 - Researchers have helped pioneer a novel approach to the development and delivery of an HIV/AIDS vaccine, which involves a female-controlled vaginal HIV vaccine. The novel method is to be tried...
Cell culture sector boosts biopharm fortunes
22-Sep-2005 - According to a new report, the biopharmaceutical market is predicted to increase from $1.4 billion (€1.14 billion) in 2003 to $2.6 billion in 2006. The market was dwarfed by the...
Restricted access barrier systems defined
22-Sep-2005 - The International Society of Pharmaceutical Engineers (ISPE) has developed a definition of restricted access barrier systems, in collaboration with the US Food and Drug Administration, in order to clear up...
Alliance aims at foam-based treatment for scabies
22-Sep-2005 - Foamix, an Israeli company specialising in the development of topical drug delivery systems, has entered into an agreement with drugmaker Stiefel Laboratories for the development of a foam-based treatment for...
Web-based pedigree system launched in US
22-Sep-2005 - PD-Rx Pharmaceuticals says it has completed the infrastructure of an online, web-based pharmaceutical tracking system - called the Pedigree Security Network - to help combat drug counterfeiting.
21-Sep-2005
New drugs, formulations driving US packaging market
21-Sep-2005 - The US market for pharmaceutical packaging will grow by nearly a third between 2004 and 2011, driven by the increasing demands placed on packaging by biologic drugs and novel drug...
FDA sets out draft cGMPs for PET drugs
21-Sep-2005 - The US Food and Drug Administration (FDA) has drafted a current Good Manufacturing Practice (cGMP) regulation for the production of drugs used in positron emission tomography (PET), a diagnostic tool.
Top execs leave Micap as losses mount
21-Sep-2005 - UK microencapsulation specialist Micap has seen the departure of both chief executive Michael Brennand and non-executive chairman Ian Gowrie Smith in a bid to cut the executive payroll.
Eisai taps India for manufacturing expertise
21-Sep-2005 - Eisai has become the first Japanese drugmaker to set up a dedicated subsidiary in India in order to tap into local expertise in manufacturing and research, according to local press...
Report blasts 'hype' over personalised medicines
21-Sep-2005 - According to a recent report, pharmacogenetics is unlikely to become a reality within the next 15-20 years having been 'hyped' by the media, who are unaware of the many gaps...
CFO resigns from troubled Andrx
21-Sep-2005 - US generics company Andrx, currently in the throes of an investigation into its manufacturing procedures by the Food and Drug Administration, announced the resignation of chief financial officer John Hanson.
20-Sep-2005
Disposable cleanroom launched by UK's RLS
20-Sep-2005 - Related Life Sciences of the UK has launched an inexpensive way of converting existing rooms into temporary isolation suites within just 10 minutes.
Biotrace expands in pharma with MicroSafe acquisition
20-Sep-2005 - Biotrace of the UK has acquired MicroSafe Group, an Italian supplier of microbiological testing products for the pharmaceutical, food and defence sectors, for £2.5 million.
Inspection specialist Key opens dedicated pharma unit
20-Sep-2005 - Key Technology has set up a dedicated pharmaceutical business unit, Symetix, to lend some focus to its efforts to sell automated inspection and specialised conveying systems to the drug industry.
Zentiva buys Sicomed in latest generics M&A
20-Sep-2005 - The consolidation in the generic pharmaceutical industry continues apace, with companies in the easterly reaches of Europe now getting in on the act. Czech Republic-headquartered Zentiva has signed an agreement...
Nanostructures build next-gen lab equipment
20-Sep-2005 - A previously unknown zinc oxide nanostructure is set to provide a new building block for creating laboratory equipment that rely on electromechanical coupling. The material's cost and flexibility makes it...
Scientists' terminator' virus destroys tumour growth
20-Sep-2005 - US scientists have claimed to have developed the next generation of effective viral-based therapies for cancer in which 'terminator' viruses are deployed to destroy primary tumours.
Orally-absorbed paclitaxel clears Phase I trial
20-Sep-2005 - French drug delivery company Novagali Pharma has completed early-stage clinical testing of an oral formulation of paclitaxel, a widely used cancer drug usually delivered by intravenous infusion.
19-Sep-2005
KemFine buys Avecia Fine Chemicals
19-Sep-2005 - KemFine, the fine chemicals business created via a management buyout from chemicals group Kemira last year, has acquired Avecia Fine Chemicals' business based in Grangemouth, Scotland.
Bonfiglioli launches in-line leak tester
19-Sep-2005 - Italy's Bonfiglioli has updated its BLI leak testing machine for blister packaging, first introduced last year, with the ability to automate sampling between the blister machine and the cartoner for...
New 'hitchhiking' virus has drug delivery potential
19-Sep-2005 - Researchers in the US have constructed a new virus-based gene therapy delivery system that has uses in cancer treatment. The findings are said to provide a solution to the problems...
GSK's first-in-class HIV drug trials halted
19-Sep-2005 - GlaxoSmithKline has halted clinical trials of its first-in-class HIV drug after cases of hepatotoxicity was discovered in treatment-naïve patients. The setback does not mean the end of development for this...
Cleanroom company Esco opens doors in US
19-Sep-2005 - Singapore-based cleanroom specialist Esco has set up its first direct presence in the US market via the opening of a new subsidiary, Esco Technologies, based in Philadelphia.
Preclinical cancer drug data reveals MM efficacy
19-Sep-2005 - A new drug candidate, which targets the protein that protects cancer cells from dying, has been shown to exhibit increased anti-tumour activity when combined with an existing cancer treatments. The...
Germany's Merck sets out stall for respiratory sector
19-Sep-2005 - Germany's Merck KGaA has laid out its plans to take on the market for generic respiratory medicines, revealing that it is the previously unnamed company that has licensed UK inhaler...
16-Sep-2005
German OK clears way for greater use of BASF excipient
16-Sep-2005 - BASF's recently introduced polymer excipient, Kollicoat IR, has been granted its first registration in a finished drug product.
ProEthic to bring Swiss delivery tech to North America
16-Sep-2005 - Applied Pharma Research, a Swiss R&D firm specialising in drug delivery, has granted an exclusive license to US drugmaker ProEthic Pharmaceuticals to develop and market two fast-acting formulations of the...
Bodycote adds to pharma services with Cirrus buy
16-Sep-2005 - UK pharmaceutical testing company Cirrus Laboratories has been acquired by Bodycote Materials Testing, an international provider of materials testing services to industry.
Wilco boosts throughput of vial tester
16-Sep-2005 - Switzerland's Wilco AG has developed a new version of its award winning headspace testing system for pharmaceutical vials that boosts its throughput by 50 per cent.
15-Sep-2005
Report sees boom time ahead for biopharma CMOs
15-Sep-2005 - Pharmaceutical companies are increasingly looking to retain their internal focus on research and development (R&D) and marketing while outsourcing their manufacturing processes, thus fueling a growing demand for the manufacturing...
Stanelco develops alternative to gelatine hardshells
15-Sep-2005 - UK-based Stanelco says it has developed a starch-based alternative to gelatine hardshell capsules that could also offer cost benefits for dietary supplement makers.
Sandoz takes issue with FDA over biogenerics
15-Sep-2005 - Sandoz, the generic drug unit of Swiss pharmaceutical group Novartis, has filed a law suit against the US Food and Drug Administration (FDA) alleging that the agency is dragging its...
European firm eyes BioSante's nanoparticle technology
15-Sep-2005 - BioSante Pharmaceuticals has licensed its calcium phosphate (CaP) nanotechnology - used for drug delivery and as an adjuvant for vaccines - to an unnamed European pharmaceutical company.
Merck and EFSD to advance novel diabetes research
15-Sep-2005 - Merck Sharp & Dohme (MSD), the UK subsidiary of Merck & Co of the US, is to partner with the European Foundation for the Study of Diabetes (EFSD), to further...
Joint project produces unique bacterial diagnosis application
15-Sep-2005 - STMicroelectronics and Mobidiag unveil a new technology that enables rapid bacterial diagnosis. The new lab-on-a-chip application allows a more accurate detection of infectious diseases that will lead to better treatment...
14-Sep-2005
Wave disposables will help make pandemic flu vaccine
14-Sep-2005 - Novavax and Wave Biotech are to collaborate on the development of a commercial scale production process for the former's pandemic influenza virus vaccine and other biological products.
Fake drug sales 'could nearly double by 2010'
14-Sep-2005 - A US think tank, The Centre for Medicines in the Public Interest, has released a new report projecting counterfeit drug sales to reach $75 billion in 2010, a 92 per cent increase from 2005.
After US, Indian packager eyes European market
14-Sep-2005 - India's largest pharmaceutical packaging company, Bilcare, is planning to open a subsidiary in Germany, shortly after announcing a major acquisition in the US, in a move that underlines its international...
DelSite seeks US OK for nasal delivery polymer
14-Sep-2005 - DelSite Biotechnologies has filed a Drug Master File (DMF) with the US Food and Drug Administration for an excipient used for drug delivery - called GelSite - used to formulate...
13-Sep-2005
DynaPro used in protein freezing studies
13-Sep-2005 - Wyatt Technology's DynaPro Titan range of dynamic light scattering (DLS) instruments can be used to determine whether freezing alters a protein's homogeneity, according to researchers in France.
Lollipop painkiller goes sugar free
13-Sep-2005 - Sugar is a useful excipient for use in medications because of its ability to mask bitter tastes, but its use in drugs intended for chronic use, or which reside in...
Lonza hikes API production capacity
13-Sep-2005 - Switzerland's Lonza has boosted its ability to make active pharmaceutical ingredients (API) at its Visp site in response to what it said was 'ever increasing hygienic and regulatory requirements'.
Viral treatment opens lab research avenues.
13-Sep-2005 - Researchers have discovered a single therapy that could treat four viral diseases, which could mean new avenues of laboratory research. The treatment focuses on viruses responsible for HIV, measles, Ebola...
Biovitrum enters trials for glaucoma drug
13-Sep-2005 - Biovitrum has initiated phase I trials for its glaucoma drug candidate that aims to improve over existing current treatments and satisfy the need in the market for new drugs with...
Lilly moves forward with inhaled insulin
13-Sep-2005 - The news that Pfizer had been granted an approval recommendation in the US for its inhaled formulation of insulin, Exubera, has been swiftly followed by the news that a rival...
12-Sep-2005
Whatman feels effects of merger in first half
12-Sep-2005 - Separations specialist Whatman is starting to reap the benefits of its acquisition of Schleicher & Schuell, but had a difficult first half to the year with the group's combined revenues...
Abuse-resistant opioid clears Phase III trial
12-Sep-2005 - A novel painkiller in development at Pain Therapeutics - based on a technology that both improves dosing and prevents drug abuse - has done well in a Phase III clinical...
Biogen Idec cuts staff and sells assets
12-Sep-2005 - US biotechnology company Biogen Idec has succumbed to the effects of having to withdraw its multiple sclerosis drug Tysabri (natalizumab) earlier this year, cutting 17 per cent of its workforce...
Hike in drug withdrawals a myth, says Tufts
12-Sep-2005 - Quicker review times by the US Food and Drug Administration has not increased the number of prescription drugs withdrawn for safety reasons in the country, according to the Tufts Centre...
Stop 'cynical use' of drug studies, say researchers
12-Sep-2005 - Scientists in research and academia have called for the end to the pharmaceutical industry's 'cynical use' of drug studies and its subjects who are often misled into taking part.
09-Sep-2005
Inhaled insulin gets green light from FDA panel
09-Sep-2005 - Diabetics moved a step closer to having an alternative to injections for their insulin therapy yesterday, after a US Food and Drug Administration (FDA) advisory committee gave its backing to...
Wyeth licenses expression system from XOMA
09-Sep-2005 - US biotechnology firm XOMA has granted Wyeth a non-exclusive, worldwide license for a technology used to make biologic drugs such as antibodies in bacteria instead of mammalian cells.
Andrx under scrutiny as FDA finds production problems
09-Sep-2005 - Generics manufacturer Andrx Corp has become the latest generic drugs manufacturer to fall foul of the US Food and Drug Administration (FDA) because of quality issues at a manufacturing plant.
08-Sep-2005
Evotec reorganises development services business
08-Sep-2005 - Anglo-German company Evotec has reorganised its pharmaceutical development services business by integrating its ProPharma subsidiary, based in Scotland, into a new structure alongside its in-house activities.
Wyeth opens $2bn biomanufacturing plant
08-Sep-2005 - Wyeth yesterday formally opened its Grange Castle biotech production facility in South County Dublin, Ireland, one of the largest integrated biotech manufacturing facilities in the world.
GSK continues apace with flu vaccine empire building
08-Sep-2005 - If there was any doubt that GlaxoSmithKline aims to become the premier world supplier of influenza vaccine, it should be laid to rest by yesterday's news that the number two...
Nasal Alzheimer's drug to enter trials
08-Sep-2005 - A clinical trial will shortly get underway to see if insulin, delivered intranasally using an atomiser developed by Kurve Technology, can improve short-term memory in Alzheimer's disease patients.
New approach in TB treatment
08-Sep-2005 - A new immunotherapeutic approach for the treatment of tuberculosis (TB) is set to open up new avenues of laboratory research that sidesteps the associated side effects of current conventional treatments...
Lab ventilation systems enter the 21st century
08-Sep-2005 - Fundamental changes are occurring in not only the way scientific research is conducted but also innovations that will drive a very different approach to laboratory design in the new millennium.
Organisations address laboratory research safeguards
08-Sep-2005 - Medical research bodies have joined together in a defiant effort to combat terrorism by issuing a statement that aims to reduce the risk of sensitive laboratory research being used in...
07-Sep-2005
3D barcode allows data-rich labelling
07-Sep-2005 - One of the difficulties facing the pharmaceutical industry is the sheer volume of information that has to be incorporated on drug labelling and packaging, which often makes designing packaging more...
Scientists strike gold in nanoparticle research
07-Sep-2005 - Scientists in the US have developed a way to rapidly generate libraries of gold nanoparticles that could have an array of applications in the pharmaceutical industry, from target and drug...
Diosynth wins contract for peptide synthesis technology
07-Sep-2005 - Akzo Nobel business unit Diosynth, which specialises in the production of complex active biopharmaceutical ingredients for the pharmaceutical sector, has won a contract to apply its new method for manufacturing...
Excipients market benefitting from pharma's woes
07-Sep-2005 - Excipients, often overlooked by pharmaceutical companies with their attention firmly focused on active pharmaceutical ingredients, are benefiting from an increasing awareness of their potential to cut the costs of drug...
GSK taps Finnish group for PAT expertise
07-Sep-2005 - A suite of optical detection methods, developed by Finnish researchers alongside world number two drugmaker GlaxoSmithKline, promises to cut the cost of drug production and increase the safety and quality...
06-Sep-2005
Metrohm unveils high-throughput titration system
06-Sep-2005 - Metrohm has developed a robotic analyser that could improve the safety and reduce the cost of non-aqueous titration experiments.
AB lays down the law on PCR
06-Sep-2005 - Applied Biosystems have taken out a permanent injunction against Bio-Rad Laboratories and its affiliate, MJ Research. This effectively forbids these companies from making and selling infringing thermal cycler products in...
Biogenerics market set to explode?
06-Sep-2005 - Regulatory obstacles to the development of the market for biogeneric drugs are falling down, and the first products are set to reach the markets of North America and Europe in...
MonoSolRx seeks DEA registration for film strip facility
06-Sep-2005 - MonoSolRx is planning to develop controlled drugs such as opioid analgesics in its dissolving films, an emerging dosage format for the oral delivery of drugs and nutritonal products.
Flamel loses another Micropump contract
06-Sep-2005 - French drug delivery company Flamel Technologies suffered another blow yesterday when it was revealed that TAP Pharmaceutical Products has pulled out of deal to develop a formulation of its big-selling...
Chiron rebuffs Novartis' takeover offer
06-Sep-2005 - US biotechnology company Chiron has rejected a takeover offer from Swiss drugmaker Novartis, saying the latter's $40 a share offer does not pass muster.
05-Sep-2005
Magnets make catalyst recovery a cinch
05-Sep-2005 - Researchers have developed a way of recovering catalysts used in the manufacture of pharmaceuticals using simple magnets, potentially doing away with the need for complex separation and purification steps.
Novartis offers $4.5bn for control of Chiron
05-Sep-2005 - Novartis has offered to buy the remaining shares it does not already own in US headquartered Chiron for $4.5 billion, laying to rest speculation in the marketplace that it had...
Indian biotech to build plant in Malaysia
05-Sep-2005 - India's leading biotechnology company, Bharat Biotech, has said it intends to spend more than €10 million on the construction of a manufacturing facility in Perak, Malaysia, to mass produce hepatitis...
Malvern unveils improved particle size analyser
05-Sep-2005 - Malvern has launched a new generation Spraytec system for particle size analysis of aerosols and sprays.
GSK invests further in flu vaccine capacity
05-Sep-2005 - GlaxoSmithKline has acquired a manufacturing facility in the USA from Wyeth, and will invest at least $100 million (€80m) to develop and produce flu vaccines at the site using new...
Biogenerics dethrones blockbusters, report claims.
05-Sep-2005 - With blockbuster patents set to expire, the biogenerics market is set to cash in as previous challenges such as a lack of regulatory framework are nearing resolve, particularly in Western...
02-Sep-2005
Technique serves as a miracle cure-all treatment
02-Sep-2005 - New techniques aimed at directly controlling the expression of genes by activating or inactivating them at the DNA level could lead to drugs for the treatment or cure of almost...
Sweet success in drug sugar studies
02-Sep-2005 - Scentists have employed a new technique to manipulate the sugars that power many front-line drugs, which has resulted in the enhancement of a drug for heart disease. Manipulating the natural...
01-Sep-2005
Carlyle invests in growing capsules market
01-Sep-2005 - In a management buy-out private equity firm The Carlyle group will invest in the hard capsules market and tap into the growing health and pharmaceutical market, acquiring four subsidiaries from...
MG2 launches capsule filling machines
01-Sep-2005 - Italian pharmaceutical dosing and packaging equipment manufacturer, MG2, has launched two new dosing machines for hard gelatine capsules, which can handle different dosing combinations in the same capsule, such as...
Tumours targeted by stealth particles
01-Sep-2005 - US researchers have developed a nanoparticle-derived shell, which they believe may some day target tumour cells and deliver medication to specific locations. The polymer shell protection ensures the drug can...
MIT's RFID project has pharma applications
01-Sep-2005 - As part of its programme to develop a seamless system for tracking goods through the supply chain, MIT's Auto-ID Laboratory is in the process of building a software simulation to...
Sigma-Aldrich launches DNA Polymerase kit
01-Sep-2005 - Sigma-Aldrich launches its DNA polymerase product for PCR amplification, which aims to minimise DNA contamination, making it ideal for researchers looking for a more accurate method in mutation scanning techniques,...
| « Previous month | Next month » |
Most Popular News
Key Industry Events
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference
Access all events listing
Products
On demand Supplier Webinars
Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment
ATMI Life Science
ATMI Life Science
